Easy task difficult life
|
|
- Mervin Rich
- 5 years ago
- Views:
Transcription
1 Carlo Fallai S.C. Radioterapia 2 Fondazione IRCCS Istituto Nazionale Tumori Milano
2
3 Easy task difficult life
4
5 T1N0 GLOTTIC CANCER
6
7
8 T1N0 Glottic cancer Initial& ultimate local control in historical series
9 Author Pts Initial LC Surg. Salvage Ult LC Lar Pres % (%) % %
10 T1N0 Glottic cancer Treatment factors: overall treatment time
11
12
13 T1N0 Glottic cancer Treatment factors: fraction size
14
15
16
17 RADIOTHERAPY FOR EARLY GLOTTIC CARCINOMA (T1N0M0): RESULTS OF PROSPECTIVE RANDOMIZED STUDY OF RADIATION FRACTION SIZE AND OVERALL TREATMENT TIME HIDEYA YAMAZAKI, M.D.,* KINJI NISHIYAMA, M.D.,* EIICHI TANAKA, M.D.,* Local control 5-year OS: 87 vs 88% Int. J. Radiation Oncology Biol. Phys., Vol. 64, No. 1, pp , 2006
18
19
20
21
22 T1N0 Glottic cancer Tumor factors: anterior commissure involvement
23
24
25
26 T2N0 GLOTTIC CANCER
27
28 T2N0 Glottic cancer Initial& ultimate local control in historical series
29
30 T2N0 Glottic cancer Treatment factors: overall treatment time
31
32 T2N0 Glottic cancer Treatment factors: fraction size
33
34 Hypofx
35
36
37
38 _
39 Mod. AJCC Impaired vc mobility
40
41
42 RTOG conclusions RTOG 9512 tested an HFX schedule in T2 glottictumors similar to schedules tested in more locally advanced disease in RTOG 9003 and EORTC Although the difference between treatment arms did notreach statistical significance, the trial outcome is consistent with gains observed for hyperfractionationin more locally advanced disease, enhancing local control by 8 points. This was achieved with low acute and late toxicity. Other effective and more convenient fractionation schedules in the management of early glotticcancer include hypofractionationat 225 cgyper fraction. Outcomes in patients with T2btumors remain suboptimaland may benefit from concurrent chemotherapy.
43 T2N0 Glottic cancer Tumor factors: subglottic extension
44
45 T2N0 Glottic cancer Tumor factors: cord mobility
46
47
48
49 T2N0 Glottic cancer Tumor factors: tumor volume
50
51
52
53 A tugof war? Radiotherapy vs Surgery
54
55 Cochrane Database Syst Rev Dec 12; Update There is only one randomised controlled trial comparing open surgery and radiotherapy but its interpretation is limited because of concerns about the adequacy of treatment regimens and deficiencies in the reporting of the study design and analysis.
56 HartlDM, Ferlito A, BrasnuDF, LangendijkJA, Rinaldo A, Silver CE, Wolf GT. S vs RT
57 HartlDM, Ferlito A, BrasnuDF, LangendijkJA, Rinaldo A, Silver CE, Wolf GT. S vs RT
58 HartlDM, Ferlito A, BrasnuDF, LangendijkJA, Rinaldo A, Silver CE, Wolf GT. S vs RT
59
60 OtolaryngolHead NeckSurg.2015 May; 152(5): Voice outcomesfollowingradiationversus laser microsurgeryfort1 glotticcarcinoma: systematic review and meta-analysis. Greulich et al. Voice Handicap Index (VHI) scores were comparable following transoral Voice Handicap Index (VHI) scores were comparable following transoral laser microsurgery and radiation therapy for T1 glottic carcinoma in the current literature, suggesting no clinically significant difference in functional voice outcomes between treatment types.
61 CONCLUSIONS Min Yao- University Case medical Center
62 CONCLUSIONS
63 CONCLUSIONS
64
65 Appendix Dedicated to radiation oncologists Early laryngeal cancer RADIATION THERAPY Technical notes
66 T1N0 Glottic cancer
67 T2N0 Larynx cancer Radiotherapy for Head and Neck Cancers Ang KA, Garden AS Eds.
68 T2N0 Glottic cancer Intensity Modulated Radiation Therapy for Head and Neck Cancer Chao KSC, Ozyigit G Eds
69 CONTOURING
70 CONTOURING
71
72 Treatment accuracy
73
74 IMRT and carotid sparing Conclusions: Elderly patients with early-stage laryngeal cancer have a high burden of cerebrovascularevents after surgical management or RT. RT and surgery are associated with comparable risk for subsequent CVD development after treatment in elderly patients. Conclusion: IMRT provided the finest planning target volume coverage with minimal RT CA doses.
75 OralOncol.2015 Jul;51(7): Carotid sparing intensity- modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma. Zumsteg et al
76
77
78
79
80
81 Thanks for your attention
T1/T2 LARYNX CANCER. Click to edit Master Presentation Date. Thomas J Gernon, MD Otolaryngology-Head and Neck Surgery
ADVANCES IN TREATMENT OF T1/T2 LARYNX CANCER Click to edit Master Presentation Date Thomas J Gernon, MD Otolaryngology-Head and Neck Surgery I have nothing to disclose CHANGING TRENDS IN HNSCC GLOTTIC
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology 2018 www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More informationProtocol of Radiotherapy for Head and Neck Cancer
106 年 12 月修訂 Protocol of Radiotherapy for Head and Neck Cancer Indication of radiotherapy Indication of definitive radiotherapy with or without chemotherapy (1) Resectable, but medically unfit, or high
More informationEvaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer
1 Charles Poole April Case Study April 30, 2012 Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer Abstract: Introduction: This study
More informationSelf-Assessment Module 2016 Annual Refresher Course
LS16031305 The Management of s With r. Lin Learning Objectives: 1. To understand the changing demographics of oropharynx cancer, and the impact of human papillomavirus on overall survival and the patterns
More informationLaryngeal Conservation
Laryngeal Conservation Sarah Rodriguez, MD Faculty Advisor: Shawn Newlands, MD, PhD The University of Texas Medical Branch Department of Otolaryngolgy Grand Rounds Presentation February 2005 Introduction
More informationLocally advanced head and neck cancer
Locally advanced head and neck cancer Radiation Oncology Perspective Petek Erpolat, MD Gazi University, Turkey Definition and Management of LAHNC Stage III or IV cancers generally include larger primary
More informationMANAGEMENT OF CA HYPOPHARYNX
MANAGEMENT OF CA HYPOPHARYNX GENERAL TREATMENT RECOMMENDATIONS BASED ON HYPOPHARYNX TUMOR STAGE For patients presenting with early-stage definitive radiotherapy alone or voice-preserving surgery are viable
More informationTREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy
TREATMENT TIME & TOBACCO: TWIN TERRORS Of H&N Therapy Anurag K. Singh, MD Professor of Medicine University at Buffalo School of Medicine Professor of Oncology Director of Radiation Research Roswell Park
More informationJMSCR Vol 06 Issue 11 Page November 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.39 Index Copernicus Value: 9.54 ISSN (e)-4-16x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i11.65 Randomised controlled trial comparing
More informationRADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.
RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1. 550 000 NEW PATIENTS/YEAR WITH HEAD AND NECK CANCER ALL
More informationCHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre
CHEMO-RADIOTHERAPY FOR BLADDER CANCER Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre AIMS Muscle invasive disease Current Gold-Standard Rationale behind Chemo-Radiotherapy
More informationTreatment for Supraglottic Ca History: : Total Laryngectomy y was routine until early 50 s, when XRT was developed Ogura and Som developed the one-sta
Role of Laser Therapy in Laryngeal Cancer Khalid Hussain AL-Qahtani MD,MSc,FRCS(c) MSc Assistant Professor Consultant of Otolaryngology Advance Head & Neck Oncology, Thyroid & Parathyroid,Microvascular
More informationUse of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. American Society of Clinical Oncology Clinical Practice Guideline
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer American Society of Clinical Oncology Clinical Practice Guideline Introduction ASCO convened an Expert Panel to develop recommendations
More informationA retrospective review in the management of T3 laryngeal squamous cell carcinoma: an expanding indication for transoral laser microsurgery
Butler et al. Journal of Otolaryngology - Head and Neck Surgery (2016) 45:34 DOI 10.1186/s40463-016-0147-1 ORIGINAL RESEARCH ARTICLE Open Access A retrospective review in the management of T3 laryngeal
More informationJosh Howard CMD Upendra Parvathaneni MBBS, FRANZCR
Anatomic and Dosimetric Correlation in the Treatment of Advanced Larynx Cancer- When is the Brachial Plexus at Risk? Josh Howard CMD Upendra Parvathaneni MBBS, FRANZCR AAMD 39th Annual Meeting - Seattle
More informationPre- Versus Post-operative Radiotherapy
Postoperative Radiation and Chemoradiation: Indications and Optimization of Practice Dislosures Clinical trial support from Genentech Inc. Sue S. Yom, MD, PhD Associate Professor UCSF Radiation Oncology
More informationDe-Escalate Trial for the Head and neck NSSG. Dr Eleanor Aynsley Consultant Clinical Oncologist
De-Escalate Trial for the Head and neck NSSG Dr Eleanor Aynsley Consultant Clinical Oncologist 3 HPV+ H&N A distinct disease entity Leemans et al., Nature Reviews, 2011 4 Good news Improved response to
More informationThe Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology
The Evolution of SBRT and Hypofractionation in Thoracic Radiation Oncology (specifically, lung cancer) 2/10/18 Jeffrey Kittel, MD Radiation Oncology, Aurora St. Luke s Medical Center Outline The history
More informationWojciech K. Mydlarz, M.D. Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue
Wojciech K. Mydlarz, M.D. Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue Disclosures No Relevant Financial Relationships or Commercial Interests Educational Objectives
More informationThe management of advanced supraglottic and
ORIGINAL ARTICLE ORGAN PRESERVATION FOR ADVANCED LARYNGEAL CARCINOMA Robert L. Foote, MD, 1 R. Tyler Foote, 1 Paul D. Brown, MD, 1 Yolanda I. Garces, MD, 1 Scott H. Okuno, MD, 2 Scott E. Strome, MD 3 1
More informationFRCS Otolarynoglogy VIVA Course Dundee Guidelines. Andrew Kinshuck ST-8 ENT Aintree University Hospital, Liverpool
FRCS Otolarynoglogy VIVA Course Dundee www.frcsentvivacourse.co.uk Guidelines Andrew Kinshuck ST-8 ENT Aintree University Hospital, Liverpool Marking Descriptors Available from JCIE website if search for
More informationPersistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer
ORIGINAL ARTICLE Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer Paul A. Tennant, MD, * Elizabeth Cash, PhD, Jeffrey M. Bumpous, MD, Kevin L. Potts,
More informationHPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV INDUCED OROPHARYNGEAL CARCINOMA radiation-oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium DISCLOSURE OF INTEREST Nothing to declare HEAD AND NECK CANCER -HPV
More informationLaser Cordectomy. Glottic Carcinoma
Laser Cordectomy in Glottic Carcinoma Department of Otolaryngology gy Head & Neck Surgery Alexandria University Historical Review Endolaryngeal extirpation of vocal cord cancers is a controversial o issue
More informationEffects of tumor staging and treatment modality on functional outcome and quality of life after treatment for laryngeal cancer
ORIGINAL ARTICLE Effects of tumor staging and treatment modality on functional outcome and quality of life after treatment for laryngeal cancer Stuart M. Robertson, FRCSGlasg(ORL-HNS), 1,2 * Justin C.
More informationQuality Variation and Clinical Impact in Head and Neck IMRT
Quality Variation and Clinical Impact in Head and Neck IMRT 6 th IMRT Symposium, New York Sep. 20, 2010 K.S. Clifford Chao, MD Chairman, Combined Radiation Oncology, New York Presbyterian Hospital Chairman,
More informationOrgan-Preservation Strategies in head and neck cancer. Teresa Bonfill Abella Oncologia Mèdica Parc Taulí Sabadell. Hospital Universitari
Organ-Preservation Strategies in head and neck cancer Teresa Bonfill Abella Oncologia Mèdica Parc Taulí Sabadell. Hospital Universitari Larynx Hypopharynx The goal of treatment is to achieve larynx preservation
More informationHead & Neck Cancer: When to Irradiate
Head & Neck Cancer: When to Irradiate ESO-ESMO Latin-America 2018 Talented students colleagues 1 > 15 different diseases for RT strategies NC NP OC OP H L 2 HPV Prognostic Marker >2010 Trial Cases Marker
More informationLaryngeal Preservation Using Radiation Therapy. Chemotherapy and Organ Preservation
1 Laryngeal Preservation Using Radiation Therapy 1903: Schepegrell was the first to perform radiation therapy for the treatment of laryngeal cancer Conventional external beam radiation produced disappointing
More informationDefinitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
Ermiş et al. Radiation Oncology (2015) 10:203 DOI 10.1186/s13014-015-0505-6 RESEARCH Open Access Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions
More informationTreatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery
Japanese Journal of Clinical Oncology, 2015, 45(3) 248 255 doi: 10.1093/jjco/hyu203 Advance Access Publication Date: 11 December 2014 Original Article Original Article Treatment outcomes of the patients
More informationHead & Neck Contouring
Head & Neck Contouring Presented by James Wheeler, MD Center for Cancer Care Goshen, IN 46526 September 12, 2014 Special Thanks to: Spencer Boulter, Director of Operations (AAMD) Adam Moore, RT(T), CMD
More informationSanguineti s (2)Comment: When it was initially published in 2003 with a median follow-up of 3.8 years (4), the RTOG study led to a change in
Commento di due Soci AIRO pubblicati su due prestigiose riviste internazionali al Trial della forastiere et al. Long term results of RTOG:91-11 (a cura di Dr. Russi e Dr. Testolin )! Forastiere)et)al.)Long/Term)Results)of)RTOG)91/11:)A)Comparison)of)
More informationHPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view. Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium
HPV POSITIVE OROPHARYNGEAL CARCINOMA the radiation oncologist point of view Prof. dr. Sandra Nuyts Dep. Radiation-Oncology UH Leuven Belgium HEAD AND NECK CANCER -HPV Change in incidence: HEAD AND NECK
More informationCombined modality treatment for N2 disease
Combined modality treatment for N2 disease Dr Clara Chan Consultant in Clinical Oncology 3 rd March 2017 Overview Background The evidence base Systemic treatment Radiotherapy Future directions/clinical
More informationPrognostic factors in squamous cell anal cancers
Prognostic factors in squamous cell anal cancers Zainul Abedin Kapacee Year 4-5 Intercalating Medical Student, University of Manchester Dr. Shabbir Susnerwala, Mr. Nigel Scott Dr. Falalu Danwata, Dr. Marcus
More informationTreatment of T1b glottic SCC: laser vs. radiationa Canadian multicenter study
Taylor et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:22 ORIGINAL RESEARCH ARTICLE Open Access Treatment of T1b glottic SCC: laser vs. radiationa Canadian multicenter study S Mark Taylor
More informationSurvey of Laryngeal Cancer at SBUH comparing 108 cases seen here from to the NCDB of 9,256 cases diagnosed nationwide in 2000
Survey of Laryngeal Cancer at comparing 108 cases seen here from 1998 2002 to the of 9,256 cases diagnosed nationwide in 2000 Stony Brook University Hospital Cancer Program Annual Report 2002-2003 Gender
More informationT3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol
ORIGINAL ARTICLE T3-T4 laryngeal cancer in The Netherlands Cancer Institute; 10-year results of the consistent application of an organ-preserving/-sacrificing protocol Adriana J. Timmermans, MD, 1 Cornedine
More informationSan Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy
San Antonio Breast Cancer Symposium 2010 Highlights Radiotherapy Kathleen C. Horst, M.D. Assistant Professor Department of Radiation Oncology Stanford University The Optimal SEquencing of Adjuvant Chemotherapy
More informationES-SCLC Joint Case Conference. Anthony Paravati Adam Yock
ES-SCLC Joint Case Conference Anthony Paravati Adam Yock Case 57 yo woman with 35 pack year smoking history presented with persistent cough and rash Chest x-ray showed a large left upper lobe/left hilar
More informationRadiation Therapy in SCLC. What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department
Radiation Therapy in SCLC What is New? Prof. Dr. Hoda Abdel Baky El Bakry Cairo Cancer Institute Radiation Oncology Department Background Overview Small Cell Lung cancer constitute about 15 % of all newly
More informationNeoplasie del laringe Diagnosi e trattamento
Neoplasie del laringe Diagnosi e trattamento Venerdì 22 maggio 2015 Alessandria Trattamenti non chirurgici: Preservazione d organo, malattia localmente avanzata Marco C Merlano A.O. S.Croce e Carle, Ospedale
More informationCitation for published version (APA): Timmermans, A. J. (2015). Advanced larynx cancer. Trends and treatment outcomes
UvA-DARE (Digital Academic Repository) Advanced larynx cancer. Trends and treatment outcomes Timmermans, A.J. Link to publication Citation for published version (APA): Timmermans, A. J. (2015). Advanced
More informationORIGINAL ARTICLE CHEMOTHERAPY ALONE FOR ORGAN PRESERVATION IN ADVANCED LARYNGEAL CANCER
ORIGINAL ARTICLE CHEMOTHERAPY ALONE FOR ORGAN PRESERVATION IN ADVANCED LARYNGEAL CANCER Vasu Divi, MD, 1 * Francis P. Worden, MD, 1,2 * Mark E. Prince, MD, 1 Avraham Eisbruch, MD, 3 Julia S. Lee, MD, 4
More informationHead and Neck Cancer Update Sandro V Porceddu
Head and Neck Cancer Update Sandro V Porceddu Director, Radiation Oncology Research Princess Alexandra Hospital, Brisbane Associate Professor, University of Queensland President, Trans Tasman Radiation
More informationClinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital
Clinical Discussion Dr Pankaj Chaturvedi Professor and Surgeon Tata Memorial Hospital chaturvedi.pankaj@gmail.com 47/M/smoker Hopkins : Transglottic lesion No cartilage infiltration but sclerosis Left
More informationCarcinoma renale (I): Posters Review. Elena Verzoni Oncologia Medica 1 SS.Oncologia Genitourinaria Fondazione IRCCS Istituto Nazionale Tumori Milano
Carcinoma renale (I): Posters Review Elena Verzoni Oncologia Medica 1 SS.Oncologia Genitourinaria Fondazione IRCCS Istituto Nazionale Tumori Milano Agenda: Best Posters in Localized RCC Surgery: CN (#
More informationNearly 60% of all cancers currently are diagnosed in patients age
648 Feasibility and Early Results of Accelerated Radiotherapy for Head and Neck Carcinoma in the Elderly Abdelkarim S. Allal, M.D. 1 Daphné Maire, M.D. 1 Minerva Becker, M.D. 2 Pavel Dulguerov, M.D. 3
More informationUtilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D.
Utilizzo delle tecniche VMAT nei trattamenti del testa collo Marta Scorsetti M.D. Radiotherapy and Radiosurgery Dpt. Istituto Clinico Humanitas, Milan, Italy. Higher doses to the tumor Better sparing of
More informationThomas Gernon, MD Otolaryngology THE EVOLVING TREATMENT OF SCCA OF THE OROPHARYNX
Thomas Gernon, MD Otolaryngology THE EVOLVING TREATMENT OF SCCA OF THE OROPHARYNX Disclosures I have nothing to disclose. 3 Changing Role of Surgery N=42,688 Chen Ay et al. Larygoscope. 2007; 117:16-21
More informationEvaluation of CO 2 Laser Surgery for Early Carcinoma Larynx
10.5005/jp-journals-10001-1066 RESEARCH ARTICLE Evaluation of CO 2 Laser Surgery for Early Carcinoma Larynx Evaluation of CO 2 Laser Surgery for Early Carcinoma Larynx 1 Vijay K Sharma, 2 Ajith Nilakantan
More informationUpdate on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer
Update on Neoadjuvant Chemotherapy (NACT) in Cervical Cancer Nicoletta Colombo, MD University of Milan-Bicocca European Institute of Oncology Milan, Italy NACT in Cervical Cancer NACT Stage -IB2 -IIA>4cm
More informationFondazione IRCCS Istituto Nazionale dei Tumori
Fondazione IRCCS Istituto Nazionale dei Tumori General info Unit Director: Riccardo Valdagni, Radiation Oncology 1 and Prostate Cancer Program Interdisciplinary and Multiprofessional Team Core Team Urologists,
More informationIndications and techniques of surgery for the primary treatment of HNSCC
Prof. Christian Simon Chef-de-service Service d ORL et chirurgie cervico-faciale Centre Hospitalier Universitaire Vaudois (CHUV) Université de Lausanne Lausanne, Suisse Indications and techniques of surgery
More informationComparison Between 4-MV and 6-MV Radiotherapy in T1N0 Glottic Cancer
The Laryngoscope VC 2016 The American Laryngological, Rhinological and Otological Society, Inc. Comparison Between 4-MV and 6-MV Radiotherapy in T1N0 Glottic Cancer Kiattisa Sommat, FRCR; Nelson Ling Fung
More informationGlottic carcinoma of the larynx is the most common
Laser carbon dioxide cordectomy versus open surgery in the treatment of glottic carcinoma: Our results MAURIZIO MAURIZI, MD, GIOVANNI ALMADORI, MD, GAETANO PLAUDETTI, MD, DE CORSO EUGENIO, MD, and JACOPO
More informationSeptember 10, Dear Dr. Clark,
September 10, 2015 Peter E. Clark, MD Chair, NCCN Bladder Cancer Guidelines (Version 2.2015) Associate Professor of Urologic Surgery Vanderbilt Ingram Cancer Center Nashville, TN 37232 Dear Dr. Clark,
More informationHypofractionated RT in Cervix Cancer. Anuja Jhingran, MD
Hypofractionated RT in Cervix Cancer Anuja Jhingran, MD Hypofractionated RT in Cervix Cancer: Clinicaltrials.gov 919 cervix trials 134 hypofractionated RT trials Prostate, breast, NSCLC, GBM 0 cervix trials
More informationEffectiveness of Chemoradiotherapy for T1b-T2 Glottic Carcinoma
Research Article imedpub Journals http://www.imedpub.com Head and Neck Cancer Research ISSN 2572-2107 DOI: 10.21767/2572-2107.100011 Abstract Effectiveness of Chemoradiotherapy for T1b-T2 Glottic Carcinoma
More informationPersistent Tracheostomy after Organ Preservation Protocol in Patients Treated for Larynx and Hypopharynx Cancer
THIEME Original Research 377 Persistent Tracheostomy after Organ Preservation Protocol in Patients Treated for Larynx and Hypopharynx Cancer Carlos Miguel Chiesa Estomba Frank Alberto Betances Reinoso
More informationORIGINAL ARTICLE. Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx
ORIGINAL ARTICLE Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx Sandro J. Stoeckli, MD; Andreas B. Pawlik, MD; Margareta Lipp, MD; Alexander Huber, MD;
More informationCombining chemotherapy and radiotherapy of the chest
How to combine chemotherapy, targeted agents and radiotherapy in locally advanced NSCLC? Dirk De Ruysscher, MD, PhD Radiation Oncologist Professor of Radiation Oncology Leuven Cancer Institute Department
More informationTransoral Robotic Surgery (TORS) for Oropharyngeal Cancer
Transoral Robotic Surgery (TORS) for Oropharyngeal Cancer Ellie Maghami, MD, FACS Professor of Otolaryngology / Head and Neck Surgery Chief, Division of Head and Neck Surgery Norman and Sadie Lee Professor
More informationThe International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology
The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology www.ifhnos.net The International Federation of Head and Neck Oncologic Societies
More informationCase Number: RT (M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Squamous Cell Carcinoma with Isolated Upper Mediastinum Nodal Metastasis with Unknown Primary: the Role and Treatment Consideration of RT with Chemotherapy Case Number: RT2009-82(M) Potential Audiences:
More informationSimultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer
Simultaneous Integrated Boost or Sequential Boost in the Setting of Standard Dose or Dose De-escalation for HPV- Associated Oropharyngeal Cancer Dawn Gintz, CMD, RTT Dosimetry Coordinator of Research and
More informationOutline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)
Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT) James Kavanaugh, MS DABR Department of Radiation Oncology Division of Medical Physics Outline Importance
More informationPalliative radiotherapy in lung cancer
New concepts and insights regarding the role of radiation therapy in metastatic disease Umberto Ricardi University of Turin Department of Oncology Radiation Oncology Palliative radiotherapy in lung cancer
More informationInternational medical oncologists, surgeons and radiation oncologists experienced in the management of head and neck cancer patients.
Aim of the educational preceptorship Treatment options for patients with unresectable head and neck cancer have been significantly expanded over the last few years. Combined modality treatment with concomitant
More informationTrimodality Therapy for Muscle Invasive Bladder Cancer
Trimodality Therapy for Muscle Invasive Bladder Cancer Brita Danielson, MD, FRCPC Radiation Oncologist, Cross Cancer Institute Assistant Professor, Department of Oncology University of Alberta Edmonton,
More informationFondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Practice teaching course in head and neck cancer, 2-4 March 2016 - Overview Head and neck cancer treatment requires multidisciplinary cooperation between
More informationStrategies of Radiotherapy for Intermediate- to High-Risk Prostate Cancer
Strategies of Radiotherapy for Intermediate- to High-Risk Prostate Cancer Daisaku Hirano, MD Department of Urology Higashi- matsuyama Municipal Hospital, Higashi- matsuyama- city, Saitama- prefecture,
More informationCase(s): How to Deal with Mixed Response Giuseppe Procopio
Case(s): How to Deal with Mixed Response Giuseppe Procopio Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Disclosures Advisory: Astellas, Bayer, GSK Consultant: Pfizer, Novartis Background Mixed
More informationTOXICITY OF TWO CISPLATIN-BASED RADIOCHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PATIENTS WITH STAGE III/IV HEAD AND NECK CANCER
ORIGINAL ARTICLE TOXICITY OF TWO CISPLATIN-BASED RADIOCHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PATIENTS WITH STAGE III/IV HEAD AND NECK CANCER Dirk Rades, MD, 1 Fabian Fehlauer, MD, 2 Mashid Sheikh-Sarraf,
More informationENDPOINTS IN ONCOLOGY- HOW LONG WILL A CANCER PATIENT SURVIVE? DR GUNJAN BAIJAL CONSULTANT RADIATION ONCOLOGY MANIPAL GOA
ENDPOINTS IN ONCOLOGY- HOW LONG WILL A CANCER PATIENT SURVIVE? DR GUNJAN BAIJAL CONSULTANT RADIATION ONCOLOGY MANIPAL GOA Why so much of cancer today? Times have changed HISTORICAL PERSPECTIVE CANCER as
More informationCase Scenario #1 Larynx
Case Scenario #1 Larynx 56 year old white female who presented with a 2 month history of hoarseness treated with antibiotics, but with no improvement. In the last 3 weeks, she has had a 15 lb weight loss,
More informationAccepted 20 April 2009 Published online 25 June 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: /hed.21179
ORIGINAL ARTICLE DOCETAXEL, CISPLATIN, AND FLUOROURACIL INDUCTION CHEMOTHERAPY FOLLOWED BY ACCELERATED FRACTIONATION/CONCOMITANT BOOST RADIATION AND CONCURRENT CISPLATIN IN PATIENTS WITH ADVANCED SQUAMOUS
More informationClinical Protontherapy Head and Neck cancer
Clinical Protontherapy Head and Neck cancer Coen Rasch Department of Radiation Oncology Academic Medical Center Amsterdam No disclosures 1 Introduction Proton vsphotonin the literature Model basedindicationprotocol
More informationDr. P. Gullane Wharton Chair Head & Neck Surgery Professor Department of Otolaryngology -Head & Neck Surgery University of Toronto
Wharton Head and Neck Centre The Toronto General Hospital Dr. P. Gullane Wharton Chair Head & Neck Surgery Professor Department of Otolaryngology -Head & Neck Surgery University of Toronto Controversies
More informationBladder Preservation Strategies for Muscle Invasive Bladder Cancer
Bladder Preservation Strategies for Muscle Invasive Bladder Cancer Jeff M. Michalski, MD, MBA, FACR, FASTRO The Carlos A. Perez Distinguished Professor of Radiation Oncology Department of Radiation Oncology
More informationSURVIVAL OUTCOMES IN EARLY GLOTTIC CARCINOMA; A SINGLE INSTITUTION EXPERIENCE
SURVIVAL OUTCOMES IN EARLY GLOTTIC CARCINOMA; A SINGLE INSTITUTION EXPERIENCE Muhammad Atif Munawar 1, Kamran Saeed 1,Tabinda Sadaf 1,Irfan Haider, Arif Jamshed 1 Department of Radiation Oncology, Shaukat
More informationService Line: Rapid Response Service Version: 1.0 Publication Date: Month XX, 2017 Report Length: 79 Pages
CADTH RAPID RESPONSE REPORT: SYSTEMATIC REVIEW Treatments for Locally Advanced Oropharyngeal Cancer: A Systematic Review of Clinical Effectiveness and Cost- Effectiveness Service Line: Rapid Response Service
More informationOral cavity cancer Post-operative treatment
Oral cavity cancer Post-operative treatment Dr. Christos CHRISTOPOULOS Radiation Oncologist Centre Hospitalier Universitaire (C.H.U.) de Limoges, France Important issues RT -techniques Patient selection
More informationManagement of the patient with Lymph Node Involvement. Michael A Henderson Peter MacCallum Cancer Center Univ of Melbourne
Management of the patient with Lymph Node Involvement Michael A Henderson Peter MacCallum Cancer Center Univ of Melbourne Lymph Node Field Recurrence Most important prognostic factor for early stage melanoma
More informationManagement of Salivary Gland Malignancies. No Disclosures or Conflicts of Interest. Anatomy 10/4/2013
Management of Salivary Gland Malignancies Daniel G. Deschler, MD Director: Division of Head and Neck Surgery Massachusetts Eye & Ear Infirmary Massachusetts General Hospital Professor Harvard Medical School
More informationTreatments for Locally Advanced Oropharyngeal Cancer: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness
CADTH RAPID RESPONSE REPORT: SYSTEMATIC REVIEW Treatments for Locally Advanced Oropharyngeal Cancer: A Systematic Review of Clinical Effectiveness and Cost-Effectiveness Service Line: Rapid Response Service
More informationGrandangolo in Radioterapia oncologica
Grandangolo in Radioterapia oncologica Gianpiero Catalano UOC Radioterapia Oncologica IRCCS MultiMedica, Sesto S. Giovanni (Mi) Istituto Clinico MultiMedica, Castellanza (Va) Prostate Topics 2012 Androgen
More informationTherapy of Non-Operable early stage NSCLC
SBRT Stage I NSCLC Therapy of Non-Operable early stage NSCLC Dr. Adnan Al-Hebshi MD, FRCR(UK), FRCP(C), ABR King Faisal Specialist Hospital & Research Centre This is our territory Early Stages NSCLC Surgical
More informationTransoral Laser Microsurgery vs Radiotherapy for Early Glottic Cancer: Study at Tertiary Care Center in India
ijhns IJHNS Transoral Laser Microsurgery vs Radiotherapy for Early Glottic Cancer: 10.5005/jp-journals-10001-1299 Study at Tertiary Care Center in India RESEARCH ARTICLE Transoral Laser Microsurgery vs
More informationHead and Neck Reirradiation: Perils and Practice
Head and Neck Reirradiation: Perils and Practice David J. Sher, MD, MPH Department of Radiation Oncology Dana-Farber Cancer Institute/ Brigham and Women s Hospital Conflicts of Interest No conflicts of
More informationPardeep Garg 1*, Parveen Kaur 2, Rajesh Vashistha 3, Rupinder Singh 4, Ishu Sharma 5. Original Research Article. Foundation, Ludhiana, Punjab, India.
Original Research Article Incidence and Severity of Oral Mucositis in Patients of Head and Neck Cancers Receiving Definitive Radiotherapy with or without Chemotherapy: A Hospital Based Study Pardeep Garg
More informationSquamous Cell Carcinoma of the Oral Cavity: Radio therapeutic Considerations
Squamous Cell Carcinoma of the Oral Cavity: Radio therapeutic Considerations Troy G. Scroggins Jr. MD Chairman, Department of Radiation Oncology Ochsner Health Systems 1 Association of Postoperative Radiotherapy
More informationSQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY
ORIGINAL ARTICLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY IN THE ELDERLY Yi-Shing Leu 1,2,3 *, Yi-Fang Chang 4, Jehn-Chuan Lee 1, Chung-Ji Liu 2,5,6, Hung-Tao Hsiao 7, Yu-Jen Chen 8, Hong-Wen Chen 8,9,
More informationAmerican College of Radiology Appropriateness Criteria VR stage I T1 glottic cancer
ACR APPROPRIATENESS CRITERIA VR American College of Radiology Appropriateness Criteria VR stage I T1 glottic cancer treatment of John A. Ridge, MD, PhD, 1* Joshua Lawson, MD, 2 Sue S. Yom, MD, PhD, 3 Madhur
More informationEmerging Role of Immunotherapy in Head and Neck Cancer
Emerging Role of Immunotherapy in Head and Neck Cancer Jared Weiss, MD Associate Professor of Medicine and Section Chief of Thoracic and Head/Neck Oncology UNC Lineberger Comprehensive Cancer Center Copyright
More informationTHE ROLE OF RADIATION THERAPY IN MANAGEMENT OF PANCREATIC ADENOCARCINOMA. TIMUR MITIN, MD, PhD
THE ROLE OF RADIATION THERAPY IN MANAGEMENT OF PANCREATIC ADENOCARCINOMA TIMUR MITIN, MD, PhD RESECTABLE DISEASE MANAGEMENT: RESECTABLE DISEASE Resection offers the only possibility of long term survival
More informationStereotactic ablative radiotherapy in early NSCLC and metastases
Stereotactic ablative radiotherapy in early NSCLC and metastases Scheduled: 0810-0830 hrs, 10 March 2012 Professor Suresh Senan Department of Radiation Oncology SABR in stage I NSCLC A major treatment
More informationCurrent Clinical Trials for Oropharyngeal SCC in the HPV Era
Current Clinical Trials for Oropharyngeal SCC in the HPV Era Dr Caroline Connell Adelaide Radiotherapy Centre Page 1 3 May, 2016 Overview Advent of HPV associated Oropharyngeal SCC aetiology/risk factors
More information